Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms

BACKGROUND: Anti-interleukin (IL)-23 agents are widely used for autoimmune disease treatment; however, the safety and risks of specific symptoms have not been systematically assessed. OBJECTIVES: The aim of this study was to summarize the characteristics and mechanisms of occurrence of five immunolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ru, Yi, Ding, Xiaojie, Luo, Ying, Li, Hongjin, Sun, Xiaoying, Zhou, Mi, Zhou, Yaqiong, Kuai, Le, Xing, Meng, Liu, Liu, Luo, Yue, Song, Jiankun, Chen, Jiale, Li, Bin, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226270/
https://www.ncbi.nlm.nih.gov/pubmed/34177909
http://dx.doi.org/10.3389/fimmu.2021.670398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226270/
https://www.ncbi.nlm.nih.gov/pubmed/34177909
http://dx.doi.org/10.3389/fimmu.2021.670398

Ejemplares similares